Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Chronic leukaemia, Chronic myeloid leukaemia (CML), Leukaemia
Results
Phase 2
This study looked at a possible vaccine treatment for people with acute myeloid leukaemia (AML) and chronic myeloid leukaemia (CML).
Recruitment start: 1 February 2011
Recruitment end: 31 August 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Christian Ottensmeier
Bloodwise
Experimental Cancer Medicine Centre (ECMC)
NIHR Efficacy and Mechanism Evaluation (EME) Programme
NIHR Clinical Research Network: Cancer
University Hospital Southampton NHS Foundation Trust
University of Southampton Clinical Trials Unit
Last reviewed: 9 February 2018
CRUK internal database number: 7442
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
